288 related articles for article (PubMed ID: 33562741)
1. Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability.
Tayoun T; Oulhen M; Aberlenc A; Farace F; Pawlikowska P
Cells; 2021 Feb; 10(2):. PubMed ID: 33562741
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
[TBL] [Abstract][Full Text] [Related]
3. Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer.
Schonhoft JD; Zhao JL; Jendrisak A; Carbone EA; Barnett ES; Hullings MA; Gill A; Sutton R; Lee J; Dago AE; Landers M; Bakhoum SF; Wang Y; Gonen M; Dittamore R; Scher HI
Cancer Res; 2020 Nov; 80(22):4892-4903. PubMed ID: 32816908
[TBL] [Abstract][Full Text] [Related]
4. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
Gupta S; Hovelson DH; Kemeny G; Halabi S; Foo WC; Anand M; Somarelli JA; Tomlins SA; Antonarakis ES; Luo J; Dittamore RV; George DJ; Rothwell C; Nanus DM; Armstrong AJ; Gregory SG
Genes Chromosomes Cancer; 2020 Apr; 59(4):225-239. PubMed ID: 31705765
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer.
Malihi PD; Graf RP; Rodriguez A; Ramesh N; Lee J; Sutton R; Jiles R; Ruiz Velasco C; Sei E; Kolatkar A; Logothetis C; Navin NE; Corn P; Aparicio AM; Dittamore R; Hicks J; Kuhn P; Zurita AJ
Clin Cancer Res; 2020 Aug; 26(15):4143-4153. PubMed ID: 32341031
[TBL] [Abstract][Full Text] [Related]
6. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
7. High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer.
Pailler E; Auger N; Lindsay CR; Vielh P; Islas-Morris-Hernandez A; Borget I; Ngo-Camus M; Planchard D; Soria JC; Besse B; Farace F
Ann Oncol; 2015 Jul; 26(7):1408-15. PubMed ID: 25846554
[TBL] [Abstract][Full Text] [Related]
8. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
Oulhen M; Pawlikowska P; Tayoun T; Garonzi M; Buson G; Forcato C; Manaresi N; Aberlenc A; Mezquita L; Lecluse Y; Lavaud P; Naltet C; Planchard D; Besse B; Farace F
NPJ Precis Oncol; 2021 Jul; 5(1):67. PubMed ID: 34272470
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of chromosomal instability in melanoma.
Kaufmann WK; Carson CC; Omolo B; Filgo AJ; Sambade MJ; Simpson DA; Shields JM; Ibrahim JG; Thomas NE
Environ Mol Mutagen; 2014 Jul; 55(6):457-71. PubMed ID: 24616037
[TBL] [Abstract][Full Text] [Related]
11. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
[TBL] [Abstract][Full Text] [Related]
12. Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials.
Salmaninejad A; Ilkhani K; Marzban H; Navashenaq JG; Rahimirad S; Radnia F; Yousefi M; Bahmanpour Z; Azhdari S; Sahebkar A
Curr Pharm Des; 2021; 27(28):3161-3169. PubMed ID: 33902409
[TBL] [Abstract][Full Text] [Related]
13. Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer.
Gupta S; Li J; Kemeny G; Bitting RL; Beaver J; Somarelli JA; Ware KE; Gregory S; Armstrong AJ
Clin Cancer Res; 2017 Mar; 23(5):1346-1357. PubMed ID: 27601596
[No Abstract] [Full Text] [Related]
14. Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells.
Su Z; Wang Z; Ni X; Duan J; Gao Y; Zhuo M; Li R; Zhao J; Ma Q; Bai H; Chen H; Wang S; Chen X; An T; Wang Y; Tian Y; Yu J; Wang D; Xie XS; Bai F; Wang J
Clin Cancer Res; 2019 Aug; 25(16):5049-5060. PubMed ID: 31113842
[TBL] [Abstract][Full Text] [Related]
15. Genomic Instability in Cancer: Teetering on the Limit of Tolerance.
Andor N; Maley CC; Ji HP
Cancer Res; 2017 May; 77(9):2179-2185. PubMed ID: 28432052
[TBL] [Abstract][Full Text] [Related]
16. Determinants and clinical implications of chromosomal instability in cancer.
Sansregret L; Vanhaesebroeck B; Swanton C
Nat Rev Clin Oncol; 2018 Mar; 15(3):139-150. PubMed ID: 29297505
[TBL] [Abstract][Full Text] [Related]
17. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
[TBL] [Abstract][Full Text] [Related]
18. Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology.
Aoki M; Shoji H; Kashiro A; Takeuchi K; Shimizu Y; Honda K
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32369927
[TBL] [Abstract][Full Text] [Related]
19. Identification of genomic signatures in circulating tumor cells from breast cancer.
Kanwar N; Hu P; Bedard P; Clemons M; McCready D; Done SJ
Int J Cancer; 2015 Jul; 137(2):332-44. PubMed ID: 25529931
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
Fujii T; Reuben JM; Huo L; Espinosa Fernandez JR; Gong Y; Krupa R; Suraneni MV; Graf RP; Lee J; Greene S; Rodriguez A; Dugan L; Louw J; Lim B; Barcenas CH; Marx AN; Tripathy D; Wang Y; Landers M; Dittamore R; Ueno NT
PLoS One; 2017; 12(9):e0185231. PubMed ID: 28957377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
